Bausch Health Companies BHC
NYSE BHC
$5.81 +0.17 (+3.02%)
As of: Sep 22, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Cash & Equivalents (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Cash & Equivalents came in at $1.8 billion in Q2 2026, up 5.67% year-over-year from $1.7 billion in Q2 2025, and up 40.49% quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Cash & Equivalents (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Cash & Equivalents across 18 years of filings, most recently posting $1.8 billion for Q2 2026.

  • In Q2 2026, Cash & Equivalents rose 5.67% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (up 5.67% YoY), while the FY2025 annual figure was $1.3 billion, up 10.84% from the prior year.
  • Cash & Equivalents came in at $1.8 billion for Q2 2026 at Bausch Health Companies, up from $1.3 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.8 billion in Q2 2026 to a low of $486.0 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $977.3 million, with a median of $853.5 million recorded in 2023.
  • Year-over-year, Cash & Equivalents sank 58.53% in 2023 and soared 190.25% in 2025.
  • Over 5 years, Cash & Equivalents stood at $564.0 million in 2022, then soared by 67.91% to $947.0 million in 2023, then grew by 24.71% to $1.2 billion in 2024, then climbed by 10.84% to $1.3 billion in 2025, then surged by 39.42% to $1.8 billion in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $1.8 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.3 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 3.66 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 886.50 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 118.35 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 127.64 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 1.83 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 360.21 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 142.75 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 223.61 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 41.25 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 3.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.83 Bn
Mar 31, 2026 1.30 Bn
Dec 31, 2025 1.31 Bn
Sep 30, 2025 1.31 Bn
Jun 30, 2025 1.73 Bn
Mar 31, 2025 1.13 Bn
Dec 31, 2024 1.18 Bn
Sep 30, 2024 719.00 Mn
Jun 30, 2024 595.00 Mn
Mar 31, 2024 733.00 Mn
Dec 31, 2023 947.00 Mn
Sep 30, 2023 760.00 Mn
Jun 30, 2023 579.00 Mn
Mar 31, 2023 518.00 Mn
Dec 31, 2022 564.00 Mn
Sep 30, 2022 486.00 Mn
Jun 30, 2022 659.00 Mn
Mar 31, 2022 1.25 Bn
Dec 31, 2021 582.00 Mn
Sep 30, 2021 690.00 Mn
API Access

Bausch Health Companies Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BHC&period=max&api_key=YOUR_API_KEY